KRAS Mutant Metastatic Colorectal Cancer
Oncology
Prevalence
135.0 / 100K
Incidence
36.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target KRAS Mutant Metastatic Colorectal Cancer?
There are 1 clinical trial targeting KRAS Mutant Metastatic Colorectal Cancer tracked by BioSniper.
What is the prevalence of KRAS Mutant Metastatic Colorectal Cancer?
The estimated prevalence of KRAS Mutant Metastatic Colorectal Cancer is approximately 135.0 per 100,000 population.
Deep-dive into KRAS Mutant Metastatic Colorectal Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis